Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
Title | FOA | Organization | Release Date | Expire Date | Purpose |
---|---|---|---|---|---|
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) | PAR-25-064 | NIMH | The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons… More | ||
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) | PAR-25-038 | NIMH | This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular… More | ||
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) | PAR-25-067 | NIMH | This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation… More | ||
NIMH Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed) | PAR-24-233 | NIMH | The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Institute of Mental Health (NIMH) R25 program… More | ||
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) | PAR-25-065 | NIMH | The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons… More | ||
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) | PAR-25-037 | NIMH | This Notice of Funding Opportunity (NOFO) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular… More | ||
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) | PAR-25-040 | NIMH | Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation… More | ||
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional) | RFA-MH-25-171 | NIMH | Guided by the goals established in BRAIN 2025: A Scientific Vision and reinforced by the Advisory Council to the Director Working Group on BRAIN 2.0 Neuroethics Subgroup, this Notice of Funding… More | ||
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) | RFA-MH-25-170 | NIMH | Guided by the goals established in BRAIN 2025: A Scientific Vision and reinforced by the Advisory Council to the Director Working Group on BRAIN 2.0 Neuroethics Subgroup, this Notice of Funding… More | ||
Notice of Special Interest (NOSI):?Advancing Data Science Research in HIV: Responding to a Dynamic, Complex, and Evolving HIV Epidemic with Artificial Intelligence/Machine Learning | NOT-MH-23-350 | NIMH | This NOFO seeks to advance data science research in HIV using cutting edge synthetic data, artificial intelligence and machine learning (AI/ML) approaches to expand our capacity to address the… More |